Cargando…
Epigenetics in ovarian cancer: premise, properties, and perspectives
Malignant ovarian tumors bear the highest mortality rate among all gynecological cancers. Both late tumor diagnosis and tolerance to available chemical therapy increase patient mortality. Therefore, it is both urgent and important to identify biomarkers facilitating early identification and novel ag...
Autores principales: | Yang, Qilian, Yang, Yuqing, Zhou, Nianxin, Tang, Kexin, Lau, Wayne Bond, Lau, Bonnie, Wang, Wei, Xu, Lian, Yang, Zhengnan, Huang, Shuang, Wang, Xin, Yi, Tao, Zhao, Xia, Wei, Yuquan, Wang, Hongjing, Zhao, Linjie, Zhou, Shengtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069741/ https://www.ncbi.nlm.nih.gov/pubmed/30064416 http://dx.doi.org/10.1186/s12943-018-0855-4 |
Ejemplares similares
-
The RNA binding protein SORBS2 suppresses metastatic colonization of ovarian cancer by stabilizing tumor-suppressive immunomodulatory transcripts
por: Zhao, Linjie, et al.
Publicado: (2018) -
Epigenetic repression of PDZ-LIM domain-containing protein 2 promotes ovarian cancer via NOS2-derived nitric oxide signaling
por: Zhao, Linjie, et al.
Publicado: (2015) -
LncRNAs: the bridge linking RNA and colorectal cancer
por: Yang, Yanfei, et al.
Publicado: (2016) -
Plasma cells shape the mesenchymal identity of ovarian cancers through transfer of exosome-derived microRNAs
por: Yang, Zhengnan, et al.
Publicado: (2021) -
Surgical stress and cancer progression: the twisted tango
por: Chen, Zhiwei, et al.
Publicado: (2019)